HiFiBiO Therapeutics

HiFiBiO Therapeutics is a biopharmaceutical company pioneering curative immunotherapies for patients with high unmet medical needs. The company leverages its proprietary Drug Intelligence Science (DIS®) platform, which combines single cell technology and AI/ML analytics to deeply understand cellular pathology across diseases. This platform supports target discovery, antibody selection, and predictive biomarker identification to enhance clinical success. Founded in 2017, HiFiBiO has completed 4 Phase I dose escalation trials, filed and cleared 6 INDs, discovered 8 clinical candidates, and established over 12 partnerships, positioning it as an innovative leader in immunotherapy drug development.

AIAntibody DrugsBiomarker IdentificationBiopharmaceuticalsDrug DiscoveryImmunotherapyMachine LearningSingle Cell Technologyhifibio.com

HiFiBiO Therapeutics

AIAntibody DrugsBiomarker IdentificationBiopharmaceuticalsDrug DiscoveryImmunotherapyMachine LearningSingle Cell Technologyhifibio.com

HQCambridge, US

Team Size49

Open JobsUnknown

Total Funding$180M

Latest Fundraise5 years ago

Join the Team

Teeming tracks opportunities at over 24,000 AI startups, then works with you to find (and land) the one you'll love.

Data Scientist

ContractNovi Sad, RS

Contract • Novi Sad, RS

Frontend Developer

InternshipAmsterdam, NL

Internship • Amsterdam, NL

Backend Developer

Full-timeNovi Sad, RS

Full-time • Novi Sad, RS

Backend Developer

ContractTel Aviv

Contract • Tel Aviv

Backend Developer

Part-timeSan Francisco, US

Part-time • San Francisco, US

Frontend Developer

Full-timeNovi Sad, RS

Full-time • Novi Sad, RS